Khiron reports 450% growth in Colombian med weed prescriptions

Khiron Life Sciences Corp. has provided a corporate update on its global medical cannabis operations, including accelerating growth of 450 per cent in its Colombian medical cannabis prescriptions, with more than 3,500 prescriptions now filled. In addition, it supplied medical cannabis to Project Twenty21 participants in the U.K., and began medical cannabis sales in Peru.

Source: Stock Watch